Type 1 Diabetes TrialNet

• Prediabetes
• Type 1

International T1D research network offering free risk screening for relatives and clinical trials to prevent or delay type 1 diabetes.

TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. Funded primarily by the US National Institutes of Health (Special Statutory Funding Program for Type 1 Diabetes), with support from Breakthrough T1D (formerly JDRF) and the American Diabetes Association. What we offer: - Pathway to Prevention: free risk screening for eligible relatives of people with T1D (ages 2-45 in the US and Canada) - Prevention studies for people at elevated risk - Newly diagnosed studies to slow progression and preserve beta cell function There are 200+ screening and study locations across the US and worldwide. Find your nearest site at trialnet.org/locations. Contact: 1-800-425-8361 (Mon-Fri, 8am-5pm ET) or info@trialnet.org

• T1D risk screening (Pathway to Prevention)
• Free screening for eligible relatives
• Autoantibody testing
• Prevention clinical trials
• Newly diagnosed clinical trials
• Beta cell preservation research
• Clinical study participation
• Family member screening programme
• T1D staging education
• Research study referrals
• At-home screening kits (US)
• Lab-based screening (Quest / LabCorp)
• International clinical trial network
• 200+ screening and study locations
• Researcher and clinician resources
• NIH-funded T1D prevention research

1201 9th Ave, 1201 9th Ave Seattle, United States